RENVELA 800 MG TABLET

SEVELAMER CARBONATE
$5.6852per EA
High Outlier

Strength

800 mg/1

NDC

58468013301

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

SEVELAMER CARBONATE

Approval Type

New Drug (NDA)

FDA Application

NDA022127

On Market Since

8/12/2009

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price History

1W

0.0%

1M

-0.4%

3M

-0.7%

6M

-0.4%

1Y

-0.5%

3Y

N/A

5Y

N/A

All

-1.6%